BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36637147)

  • 1. Randomized double-blind placebo-controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and use of corticosteroids in children and adolescents with atopic dermatitis.
    Feíto-Rodríguez M; Ramírez-Boscà A; Vidal-Asensi S; Fernández-Nieto D; Ros-Cervera G; Alonso-Usero V; Prieto-Merino D; Núñez-Delegido E; Ruzafa-Costas B; Sánchez-Pellicer P; Genovés S; Navarro-López V
    Clin Exp Dermatol; 2023 Apr; 48(5):495-503. PubMed ID: 36637147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial.
    Gerasimov SV; Vasjuta VV; Myhovych OO; Bondarchuk LI
    Am J Clin Dermatol; 2010; 11(5):351-61. PubMed ID: 20642296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.
    Navarro-López V; Ramírez-Boscá A; Ramón-Vidal D; Ruzafa-Costas B; Genovés-Martínez S; Chenoll-Cuadros E; Carrión-Gutiérrez M; Horga de la Parte J; Prieto-Merino D; Codoñer-Cortés FM
    JAMA Dermatol; 2018 Jan; 154(1):37-43. PubMed ID: 29117309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study.
    Wu YJ; Wu WF; Hung CW; Ku MS; Liao PF; Sun HL; Lu KH; Sheu JN; Lue KH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):684-692. PubMed ID: 26733351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS).
    Torrelo A; Rewerska B; Galimberti M; Paller A; Yang CY; Prakash A; Zhu D; Pontes Filho MAG; Wu WS; Eichenfield LF
    Br J Dermatol; 2023 Jul; 189(1):23-32. PubMed ID: 36999560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness of Probiotic
    Cukrowska B; Ceregra A; Maciorkowska E; Surowska B; Zegadło-Mylik MA; Konopka E; Trojanowska I; Zakrzewska M; Bierła JB; Zakrzewski M; Kanarek E; Motyl I
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome.
    Woo SI; Kim JY; Lee YJ; Kim NS; Hahn YS
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):343-8. PubMed ID: 20408346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months.
    Diepgen TL;
    Pediatr Allergy Immunol; 2002 Aug; 13(4):278-86. PubMed ID: 12390444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
    Simpson EL; Gooderham M; Wollenberg A; Weidinger S; Armstrong A; Soung J; Ferrucci S; Lima RG; Witte MM; Xu W; ElMaraghy H; Natalie CR; Pierce E; Blauvelt A;
    JAMA Dermatol; 2023 Feb; 159(2):182-191. PubMed ID: 36630140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure.
    Wang IJ; Wang JY
    Clin Exp Allergy; 2015 Apr; 45(4):779-87. PubMed ID: 25600169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
    Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S
    Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
    Paller AS; Simpson EL; Siegfried EC; Cork MJ; Wollenberg A; Arkwright PD; Soong W; Gonzalez ME; Schneider LC; Sidbury R; Lockshin B; Meltzer S; Wang Z; Mannent LP; Amin N; Sun Y; Laws E; Akinlade B; Dillon M; Kosloski MP; Kamal MA; Dubost-Brama A; Patel N; Weinreich DM; Yancopoulos GD; O'Malley JT; Bansal A;
    Lancet; 2022 Sep; 400(10356):908-919. PubMed ID: 36116481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double- blind, placebo- controlled trial.
    D'Auria E; Panelli S; Lunardon L; Pajoro M; Paradiso L; Beretta S; Loretelli C; Tosi D; Perini M; Bedogni G; Abdelsalam A; Fiorina P; Bandi C; Zuccotti GV
    Pharmacol Res; 2021 Jan; 163():105284. PubMed ID: 33157233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
    Bieber T; Reich K; Paul C; Tsunemi Y; Augustin M; Lacour JP; Ghislain PD; Dutronc Y; Liao R; Yang FE; Brinker D; DeLozier AM; Meskimen E; Janes JM; Eyerich K;
    Br J Dermatol; 2022 Sep; 187(3):338-352. PubMed ID: 35484697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
    Chan S; Cornelius V; Cro S; Harper JI; Lack G
    JAMA Pediatr; 2020 Jan; 174(1):29-37. PubMed ID: 31764962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Oral Administration of a Heat-Treated Lactobacillus paracasei  Supplement in Infants with Atopic Dermatitis Receiving Topical Corticosteroid Therapy.
    Yan DC; Hung CH; Sy LB; Lue KH; Shih IH; Yang CY; Chen LC; Sun HL; Lee MS; Chambard J; Tanguy J; Hughes-Formella B; Nutten S; Blanchard C
    Skin Pharmacol Physiol; 2019; 32(4):201-211. PubMed ID: 31117100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis.
    Han Y; Kim B; Ban J; Lee J; Kim BJ; Choi BS; Hwang S; Ahn K; Kim J
    Pediatr Allergy Immunol; 2012 Nov; 23(7):667-73. PubMed ID: 23050557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.